Melanocortin receptors: perspectives for novel drugs.

The cloning of five different subtypes of melanocortin receptor subtypes have recently opened up new possibilities for the development of drugs. The physiological roles of the five melanocortin receptors have started to become understood, and compounds with selective actions on some of the five subtypes have become available. Presently, most clinically promising application for drugs active on melanocortin receptors are for control of feeding homeostasis and body weight and for treatment of inflammatory diseases. I review here the cloning, localisation, function and structure of the melanocortin receptors, in relation to the possibilities to develop selective drugs for these receptors.

[1]  J. M. Lipton,et al.  α-MSH Modulates Local and Circulating Tumor Necrosis Factor-α in Experimental Brain Inflammation , 1997, The Journal of Neuroscience.

[2]  Walter H. Kaye.  Anorexia nervosa, obsessional behavior, and serotonin. , 1997, Psychopharmacology bulletin.

[3]  G. Wolterink,et al.  Structure‐Activity Studies on the Neuroactive and Neurotropic Effects of Neuropeptides Related to ACTH , 1988, Annals of the New York Academy of Sciences.

[4]  V. Hruby,et al.  Design of a new class of superpotent cyclic α-melanotropins based on quenched dynamic simulations , 1989 .

[5]  J. Wild,et al.  Melanocortin-4 receptor mRNA expression in the developing autonomic and central nervous systems. , 1998, Brain research. Developmental brain research.

[6]  S. Manna,et al.  α-Melanocyte-Stimulating Hormone Inhibits the Nuclear Transcription Factor NF-κB Activation Induced by Various Inflammatory Agents , 1998, The Journal of Immunology.

[7]  I. Housini,et al.  Alpha-melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. , 1997, The Journal of clinical investigation.

[8]  J. Burbach,et al.  Expression of melanocortin-5 receptor in secretory epithelia supports a functional role in exocrine and endocrine glands. , 1998, Endocrinology.

[9]  J. Wikberg,et al.  Polyclonal antibodies against human melanocortin MC1 receptor: preliminary immunohistochemical localisation of melanocortin MC1 receptor to malignant melanoma cells. , 1995, European journal of pharmacology.

[10]  G. Franzoso,et al.  Structure, regulation and function of NF-kappa B. , 1994, Annual review of cell biology.

[11]  J. Wikberg,et al.  Evidence for involvement of the melanocortin MC4 receptor in the effects of leptin on food intake and body weight. , 1998, European journal of pharmacology.

[12]  N. Copeland,et al.  A transgenic mouse assay for agouti protein activity. , 1995, Genetics.

[13]  D. I. Våge,et al.  A non-epistatic interaction of agouti and extension in the fox, Vulpes vulpes , 1997, Nature Genetics.

[14]  J. M. Lipton,et al.  The neuropeptide alpha-melanocyte-stimulating hormone inhibits experimental arthritis in rats. , 1994, Neuroimmunomodulation.

[15]  S. Leibowitz,et al.  Neuropeptide Y chronically injected into the hypothalamus: A powerful neurochemical inducer of hyperphagia and obesity , 1986, Peptides.

[16]  M. Parmentier,et al.  Molecular cloning of a mouse melanocortin 5 receptor gene widely expressed in peripheral tissues. , 1994, Biochemistry.

[17]  P. Prusis,et al.  A three dimensional model for the interaction of MSH with the melanocortin-1 receptor. , 1995, Biochemical and biophysical research communications.

[18]  P. Morgan,et al.  Cloning and expression of a new member of the melanocyte-stimulating hormone receptor family. , 1994, Journal of molecular endocrinology.

[19]  J. Wikberg,et al.  Postnatal Expression of Melanocortin-3 Receptor in Rat Diencephalon and Mesencephalon , 1997, Neuropharmacology.

[20]  J. Wikberg,et al.  Selective antagonist for the melanocortin 4 receptor (HS014) increases food intake in free-feeding rats. , 1998, Biochemical and biophysical research communications.

[21]  J. M. Lipton,et al.  The protective effects of α-melanocyte stimulating hormone on canine brain stem ischemia , 1997 .

[22]  B. Henderson,et al.  Inhibition by neuropeptides of interleukin‐1β‐induced, prostaglandin‐independent hyperalgesia , 1989, British journal of pharmacology.

[23]  J. Wikberg,et al.  Evidence that orexigenic effects of melanocortin 4 receptor antagonist HS014 are mediated by neuropeptide Y. , 1998, Biochemical and biophysical research communications.

[24]  P. Prusis,et al.  Binding of cyclic and linear MSH core peptides to the melanocortin receptor subtypes. , 1997, European journal of pharmacology.

[25]  P. Prusis,et al.  Discovery of novel melanocortin4 receptor selective MSH analogues , 1998, British journal of pharmacology.

[26]  P. Prusis,et al.  Evidence indicating that the TM4, EL2, and TM5 of the melanocortin 3 receptor Do not participate in ligand binding. , 1996, Biochemical and biophysical research communications.

[27]  G. Ghanem,et al.  Modulation of ICAM‐1 expression by α‐MSH in human melanoma cells and melanocytes , 1998, Journal of cellular physiology.

[28]  J. Wikberg,et al.  Selective melanocortin MC4 receptor blockage reduces immobilization stress-induced anorexia in rats. , 1999, European journal of pharmacology.

[29]  M. Tota,et al.  ART (protein product of agouti-related transcript) as an antagonist of MC-3 and MC-4 receptors. , 1997, Biochemical and biophysical research communications.

[30]  Y. Konda,et al.  Molecular cloning, expression, and characterization of a fifth melanocortin receptor. , 1994, Biochemical and biophysical research communications.

[31]  R. Duman,et al.  Melanocortins and opiate addiction. , 1997, Life sciences.

[32]  J. Wikberg,et al.  Immunological localisation of melanocortin 1 receptor on the cell surface of WM266-4 human melanoma cells. , 1996, Cancer letters.

[33]  V. Chhajlani,et al.  Distribution of cDNA for melanocortin receptor subtypes in human tissues. , 1996, Biochemistry and molecular biology international.

[34]  R. Adan,et al.  Melanocortins and cardiovascular regulation. , 1998, European journal of pharmacology.

[35]  W. Meyerhof,et al.  Molecular cloning of a bovine MSH receptor which is highly expressed in the testis , 1994, FEBS letters.

[36]  A. Vergoni,et al.  Corticotropin inhibits food intake in rats , 1986, Neuropeptides.

[37]  J. Wikberg,et al.  Characterization of the binding of MSH-B, HP-228, GHRP-6 and 153N-6 to the human melanocortin receptor subtypes , 1997, Neuropeptides.

[38]  P. Prusis,et al.  Evidence for Alternate Points of Attachment for α-MSH and Its Stereoisomer (Nle4,D-Phe7)-α-MSH at the Melanocortin-1 Receptor , 1994 .

[39]  Ximena Opitz-Araya,et al.  Exocrine Gland Dysfunction in MC5-R-Deficient Mice: Evidence for Coordinated Regulation of Exocrine Gland Function by Melanocortin Peptides , 1997, Cell.

[40]  T. Luger,et al.  The Role of α-Melanocyte-Stimulating Hormone in Cutaneous Biology , 1997 .

[41]  T. Luger,et al.  Human dermal microvascular endothelial cells express the melanocortin receptor type 1 and produce increased levels of IL-8 upon stimulation with alpha-melanocyte-stimulating hormone. , 1997, Journal of immunology.

[42]  J. Burbach,et al.  Identification of antagonists for melanocortin MC3, MC4 and MC5 receptors. , 1994, European journal of pharmacology.

[43]  J. Wikberg,et al.  Characterisation of the melanocortin 4 receptor by radioligand binding. , 1996, Pharmacology & toxicology.

[44]  P. Cowen,et al.  Symptomatic relapse in bulimia nervosa following acute tryptophan depletion. , 1999, Archives of general psychiatry.

[45]  M. Mortrud,et al.  Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[46]  J. Wikberg,et al.  The melanocortin 1, 3, 4 or 5 receptors do not have a binding epitope for ACTH beyond the sequence of alpha-MSH. , 1997, The Journal of endocrinology.

[47]  J. Wikberg,et al.  Phage Display Selection on Whole Cells Yields a Peptide Specific for Melanocortin Receptor 1* , 1997, The Journal of Biological Chemistry.

[48]  R. Cone,et al.  Targeted Disruption of the Melanocortin-4 Receptor Results in Obesity in Mice , 1997, Cell.

[49]  W. Wilkison,et al.  Linkage and Association Studies between the Melanocortin Receptors 4 and 5 Genes and Obesity-Related Phenotypes in the Québec Family Study , 1997, Molecular medicine.

[50]  Richard P. Woychik,et al.  Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor , 1994, Nature.

[51]  R. Palmiter,et al.  Attenuation of the Obesity Syndrome of ob/ob Mice by the Loss of Neuropeptide Y , 1996, Science.

[52]  S. Woods,et al.  Leptin Increases Hypothalamic Pro-opiomelanocortin mRNA Expression in the Rostral Arcuate Nucleus , 1997, Diabetes.

[53]  J. M. Lipton,et al.  A potential mechanism of local anti-inflammatory action of alpha-melanocyte-stimulating hormone within the brain: modulation of tumor necrosis factor-alpha production by human astrocytic cells. , 1997, Neuroimmunomodulation.

[54]  J. Wikberg,et al.  Selectivity of [Phe-I7], [Ala6], and [d-Ala4,Gln5,Tyr6] Substituted ACTH(4-10) Analogues for the Melanocortin Receptors , 1997, Peptides.

[55]  J. M. Lipton,et al.  Binding of anti-inflammatory alpha-melanocyte-stimulating-hormone peptides and proinflammatory cytokines to receptors on melanoma cells. , 1994, Neuroimmunomodulation.

[56]  R. Cone,et al.  Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors. , 1995, Journal of medicinal chemistry.

[57]  J. Buggy.  Binding of alpha-melanocyte-stimulating hormone to its G-protein-coupled receptor on B-lymphocytes activates the Jak/STAT pathway. , 1998, The Biochemical journal.

[58]  J. Wikberg,et al.  Evidence indicating that the extracellular loops of the mouse MC5 receptor do not participate in ligand binding , 1998, Molecular and Cellular Endocrinology.

[59]  S. Takeuchi,et al.  Melanocortin receptor genes in the chicken--tissue distributions. , 1998, General and comparative endocrinology.

[60]  C. Grunfeld,et al.  Characterization of adrenocorticotropin receptors that appear when 3T3-L1 cells differentiate into adipocytes. , 1985, Endocrinology.

[61]  S. Watson,et al.  Molecular cloning of a novel melanocortin receptor. , 1993, The Journal of biological chemistry.

[62]  G. Ermak,et al.  Production of POMC, CRH-R1, MC1, and MC2 receptor mRNA and expression of tyrosinase gene in relation to hair cycle and dexamethasone treatment in the C57BL/6 mouse skin. , 1997, The Journal of investigative dermatology.

[63]  J. Wikberg,et al.  Long-term administration of MC4 receptor antagonist HS014 causes hyperphagia and obesity in rats. , 1999, Neuroreport.

[64]  D. Cook,et al.  Characterisation of ACTH peptides in human skin and their activation of the melanocortin-1 receptor. , 1997, Pigment cell research.

[65]  R. Cone,et al.  Identification of common polymorphisms in the coding sequence of the human MSH receptor (MCIR) with possible biological effects , 1997, Human mutation.

[66]  J. Wikberg,et al.  Discovery of a novel superpotent and selective melanocortin-4 receptor antagonist (HS024): evaluation in vitro and in vivo. , 1998, Endocrinology.

[67]  J. M. Lipton,et al.  Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-melanocyte-stimulating hormone. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[68]  R. Seeley,et al.  Melanocortin receptors in leptin effects , 1997, Nature.

[69]  P Herzyk,et al.  Modeling of the three-dimensional structure of the human melanocortin 1 receptor, using an automated method and docking of a rigid cyclic melanocyte-stimulating hormone core peptide. , 1997, Journal of molecular graphics & modelling.

[70]  J. Wikberg,et al.  Localization of ACTH receptor mRNA by in situ hybridization in mouse adrenal gland , 1996, Cell and Tissue Research.

[71]  J. White,et al.  Lipolytic action of corticotropin on rat adipose tissue in vitro. , 1958, The Journal of clinical investigation.

[72]  M. Berlan,et al.  Control of lipolysis in intra-abdominal fat cells of nonhuman primates: comparison with humans. , 1995, Journal of lipid research.

[73]  Kistler‐Heer,et al.  Different Developmental Patterns of Melanocortin MC3 and MC4 Receptor mRNA: Predominance of Mc4 in Fetal Rat Nervous System , 1998, Journal of neuroendocrinology.

[74]  A. Grüters,et al.  Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans , 1998, Nature Genetics.

[75]  D. Ben-Tovim,et al.  Eating disorders revisited. I: anorexia nervosa , 1998, The Medical journal of Australia.

[76]  F. Hamers,et al.  Beneficial effects of the melanocortin alpha-melanocyte-stimulating hormone on clinical and neurophysiological recovery after experimental spinal cord injury. , 1997, Neurosurgery.

[77]  G. Barsh,et al.  Structure and function of ASP, the human homolog of the mouse agouti gene. , 1995, Human molecular genetics.

[78]  M. Mortrud,et al.  Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. , 1994, Molecular endocrinology.

[79]  H. Schiöth,et al.  Deletions of the N‐terminal regions of the human melanocortin receptors , 1997, FEBS letters.

[80]  J. Wikberg,et al.  Molecular cloning of a novel human melanocortin receptor. , 1993, Biochemical and biophysical research communications.

[81]  J. M. Lipton,et al.  Peptide Modulation of Inflammatory Processes within the Brain , 1998, Neuroimmunomodulation.

[82]  Ian Jackson,et al.  Variants of the melanocyte–stimulating hormone receptor gene are associated with red hair and fair skin in humans , 1995, Nature Genetics.

[83]  V. Hruby,et al.  Linear and cyclic alpha-melanotropin [4-10]-fragment analogues that exhibit superpotency and residual activity. , 1989, Pigment cell research.

[84]  P. Farthing,et al.  Direct effects of corticotrophin on oral keratinocyte cell proliferation. , 1998, European journal of biochemistry.

[85]  J. M. Lipton,et al.  The neuropeptide α-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro , 1996, Peptides.

[86]  J. Wikberg,et al.  Expression of melanocortin 1 receptor in periaqueductal gray matter. , 1995, Neuroreport.

[87]  J. B. Tatro.  Receptor biology of the melanocortins, a family of neuroimmunomodulatory peptides. , 1996, Neuroimmunomodulation.

[88]  D. Bortner,et al.  Overexpression of an Agouti cDNA in the skin of transgenic mice recapitulates dominant coat color phenotypes of spontaneous mutants. , 1996, Developmental biology.

[89]  J. Wikberg,et al.  Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA , 1992, FEBS letters.

[90]  M. Perretti,et al.  α-melanocyte-stimulating hormone reduces interleukin-lβ effects on rat stomach preparations possibly through interference with a type I receptor , 1991 .

[91]  J. Wikberg,et al.  Major pharmacological distinction of the ACTH receptor from other melanocortin receptors. , 1996, Life sciences.

[92]  B. Berk,et al.  Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor , 1995, Nature.

[93]  P. Prusis,et al.  Selectivity of Cyclic [d-Nal7] and [d-Phe7] Substituted MSH Analogues for the Melanocortin Receptor Subtypes , 1997, Peptides.

[94]  R. Duman,et al.  Morphine down-regulates melanocortin-4 receptor expression in brain regions that mediate opiate addiction. , 1996, Molecular pharmacology.

[95]  E. Larsson,et al.  Immunohistochemical detection of the melanocortin 1 receptor in human testis, ovary and placenta using specific monoclonal antibody. , 1997, Hormone research.

[96]  A. Vergoni,et al.  ACTH-(1–24) and α-MSH antagonize feeding behavior stimulated by kappa opiate agonists , 1986, Peptides.

[97]  W. Wilkison,et al.  Agouti antagonism of melanocortin binding and action in the B16F10 murine melanoma cell line. , 1995, Biochemistry.

[98]  R. Cone,et al.  Induction of neuropeptide Y gene expression in the dorsal medial hypothalamic nucleus in two models of the agouti obesity syndrome. , 1997, Molecular endocrinology.

[99]  J. Wikberg,et al.  Autoradiographic discrimination of melanocortin receptors indicates that the MC3 subtype dominates in the medial rat brain , 1998, Brain Research.

[100]  P. Prusis,et al.  Characterisation of D117A and H260A mutations in the melanocortin 1 receptor , 1997, Molecular and Cellular Endocrinology.

[101]  Victor J. Hruby,et al.  Role of melanocortinergic neurons in feeding and the agouti obesity syndrome , 1997, Nature.

[102]  M. Mortrud,et al.  The cloning of a family of genes that encode the melanocortin receptors. , 1992, Science.

[103]  J. Nadeau,et al.  Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function , 1993, Cell.

[104]  J. Catravas,et al.  HP-228, a novel synthetic peptide, inhibits the induction of nitric oxide synthase in vivo but not in vitro. , 1995, The Journal of pharmacology and experimental therapeutics.

[105]  C. Humblet,et al.  Three-dimensional molecular models of the hMC1R melanocortin receptor: complexes with melanotropin peptide agonists. , 1996, Drug design and discovery.

[106]  M. Mihm,et al.  ACTH receptor, CYP11A1, CYP17 and CYP21A2 genes are expressed in skin. , 1996, The Journal of clinical endocrinology and metabolism.

[107]  J. Ramachandran,et al.  Studies of corticotropin receptors on rat adipocytes. , 1983, Archives of biochemistry and biophysics.

[108]  P. Frändberg,et al.  Glutamine235 and arginine272 in human melanocortin 5 receptor determines its low affinity to MSH. , 1997, Biochemical and biophysical research communications.

[109]  R. Cone,et al.  Characterization of melanocortin receptor subtype expression in murine adipose tissues and in the 3T3-L1 cell line. , 1996, Endocrinology.

[110]  J. Shutter,et al.  Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. , 1997, Genes & development.

[111]  C. Mantzoros,et al.  Cerebrospinal fluid leptin in anorexia nervosa: correlation with nutritional status and potential role in resistance to weight gain. , 1997, The Journal of clinical endocrinology and metabolism.

[112]  J. M. Lipton,et al.  α-MSH Modulates Experimental Inflammatory Bowel Disease , 1997, Peptides.